Address correspondence to Przemyslaw Przewratil, M.D., Ph.D., Department of Pediatric Surgery & Oncology, University Hospital No. 4, Medical University of Lodz, Sporna Str 36/50, 91-738 Lodz, Poland, or e-mail: [email protected].

Results of the above study were presented during the II World Congress of Pediatric Surgeons in Buenos Aires, Argentina, September 2007.

Read the full text

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

Abstract

Abstract: Impaired balance between proangiogenic and antiangiogenic factors has been implicated in the development of hemangiomas. Elevated vascular endothelial growth factor serum levels and basic fibroblastic growth factor urine levels in patients with proliferating hemangiomas were reported. However, whether these growth factors can be used for the differential diagnosis of vascular anomalies or assessment of the clinical course of hemangiomas has yet to be determined. We report here our preliminary results of serum vascular endothelial growth factor and basic fibroblastic growth factor levels as an aid in the diagnosis of hemangiomas and in the follow up of patients with this lesion. Twenty two children with infantile hemangioma (13 with proliferating hemangiomas, nine with involuting lesions), five children with vascular malformations, and 25 healthy children study group. Vascular endothelial growth factor and basic fibroblastic growth factor serum levels were analyzed by an ELISA assay. The serum vascular endothelial growth factor concentrations in children with proliferating hemangiomas were significantly higher than in patients with involuting hemangiomas, vascular malformations and healthy patients. The serum basic fibroblastic growth factor concentrations were low and similar in all patients with no statistical correlation between study groups. We concluded that (i) ELISA can easily determine vascular endothelial growth factor concentrations in different phases of hemangioma growth and help distinguishing them from vascular malformations. (ii) A potential role for vascular endothelial growth factor in the pathophysiology of hemangiomas is probable.

References

1 Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412–422.
10.1097/00006534-198203000-00002
CAS PubMed Web of Science® Google Scholar
2 Chang MW. Updated classification of hemangiomas and other vascular anomalies. Lymphat Res Biol 2003; 1: 259–265.
10.1089/153968503322758067
PubMed Google Scholar
3 Smolinski KN, Yan AC. Hemangiomas of infancy: clinical and biological characteristics. Clin Pediatr (Phila) 2005; 44: 747–766.
10.1177/000992280504400902
PubMed Web of Science® Google Scholar
4 Enjolras O, Wassef M, Chapot R. Color atlas of vascular tumors and vascular malformations. Cambridge: Cambridge University Press, 2007.
10.1017/CBO9780511722073
Google Scholar
5 Greene AK, Fishman SJ. Angiogenesis and vascular anomalies. In: KT Oldham, ed. Principles and practice of pediatric surgery, Vol. 1. Philadelphia, PA: Lippincott Williams & Wilkins, 2005: 535–548.
Google Scholar
6 Frieden IJ, Haggstrom AN, Drolet BA et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a Research Workshop on Infantile Hemangiomas. April 7–9, 2005, Bethesda, Maryland. Pediatr Dermatol 2005; 22: 383–406.
10.1111/j.1525-1470.2005.00102.x
PubMed Google Scholar
7 Gupta K, Zhang J. Angiogenesis: a curse or cure? Postgrad Med J 2005; 81: 236–242.
10.1136/pgmj.2004.023309
CAS PubMed Web of Science® Google Scholar
8 Zhang Li, Xiaoxi Lin, Wei Wang et al. Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation. Plast Reconstr Surg 2005; 116: 200–204.
10.1097/01.PRS.0000170804.80834.5F
CAS PubMed Web of Science® Google Scholar
9 Dosquet C, Coudert MC, Wassef M et al. Importance of bFGF for diagnosis and treatment of hemangioma. Ann Dermatol Venerol 1998; 125: 313–316. (in French)
CAS PubMed Web of Science® Google Scholar
10 Palgan I, Wysocki M, Szaflarska-Poplawska A et al. Evaluation of VEGF and bFGF serum levels with solid tumors – a preliminary report [in Polish]. Pol J Pediatr 2005; 80: 1096–1101.
Google Scholar
11 Walsh DA. Pathophysiological mechanisms of angiogenesis. Adv Clin Chem 2007; 44: 187–221.
10.1016/S0065-2423(07)44006-9
CAS PubMed Web of Science® Google Scholar
12 Frischer JS, Huang J, Serur A et al. Biomolecular markers and involution of hemangiomas. J Pediatr Surg 2004; 39: 400–404.
10.1016/j.jpedsurg.2003.11.043
PubMed Web of Science® Google Scholar
13 Tan ST, Velickovic M, Ruger BM et al. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg 2000; 106: 529–538.
10.1097/00006534-200009010-00001
CAS PubMed Web of Science® Google Scholar
14 Blei F. Basic science and clinical aspects of vascular anomalies. Curr Opin Pediatr 2005; 17: 501–509.
10.1097/01.mop.0000171322.76429.80
PubMed Web of Science® Google Scholar
15 Tille JC, Pepper MS. Hereditary vascular anomalies: new insight into their pathogenesis. Artherioscler Thromb Vasc Biol 2004; 24: 1578–1590.
10.1161/01.ATV.0000137390.56554.df
CAS PubMed Web of Science® Google Scholar
16 Ribatti D. The crucial role of vascular permeability factor/vascular endothelial factor in angiogenesis: a historical review. Br J Haematol 2005; 128: 303–309.
10.1111/j.1365-2141.2004.05291.x
CAS PubMed Web of Science® Google Scholar
17 Kleinman ME, Greives MR, Churgin SS. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 2007; 27: 2664–2670.
10.1161/ATVBAHA.107.150284
CAS PubMed Web of Science® Google Scholar
18 Zhang GY, Yi ChG, Li X et al. Proliferation hemangiomas formation through dual mechanism of vascular endothelial growth factor mediated endothelial progenitor cells proliferation and mobilization through matrix metlloproteinases 9. Med Hypotheses 2008; 70: 815–818.
10.1016/j.mehy.2007.06.042
CAS PubMed Web of Science® Google Scholar
19 Soldi R, Mitola S, Strasly M et al. Role of α_Vβ₃ integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999; 18: 882–892.
10.1093/emboj/18.4.882
CAS PubMed Web of Science® Google Scholar
20 Miller AM, Sandler AD. Elevated plasma vascular endothelial growth levels in 2 patients with hemangioendothelioma. J Pediatr Surg 2005; 40: E17–E19.
10.1016/j.jpedsurg.2005.02.014
PubMed Web of Science® Google Scholar
21 Barrientos S, Stojadinovic O, Golinko M et al. Growth factors and cytokines in wound healing. Wound Repair Regen 2008; 16: 585–601.
10.1111/j.1524-475X.2008.00410.x
PubMed Web of Science® Google Scholar
22 Marler JJ, Fishman SJ, Kilroy SM. Increased expression of urinary matrix metalloproteinases parallels extent and activity of vascular anomalies. Pediatrics 2005; 116: 38–45.
10.1542/peds.2004-1518
PubMed Web of Science® Google Scholar
23 Gleizes PE, Noaillac Depeyre J, Amalric F et al. Basic fibroblast growth factor (FGF-2) internalization through the heparin sulfate proteoglycans-mediated pathway: an ultrastructural approach. Eur J Cell Biol 1995; 66: 47–59.
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume26, Issue4

July/August 2009

Pages 399-404

Serum Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Children with Hemangiomas and Vascular Malformations—Preliminary Report

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Serum Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Children with Hemangiomas and Vascular Malformations—Preliminary Report

Abstract

References

Citing Literature

References

Related

Information